Skip to content
Markets
SPY689.81▼ -3.64%QQQ608.45▼ -5.67%DIA481.08▼ -1.87%GLD322.87▼ -3.67%TLT81.45▲ +1.37%BABA81.08▼ -2.68%NIO2.45▼ -7.89%PDD83.68▼ -2.70%Realtime derived data
Octans ResearchOCTANS RESEARCHWaitlist
The columned facade of the former Pacific Coast Stock Exchange building at 301 Pine Street, San Francisco, 2021.
Source: DestinationFearFan, CC BY-SA 4.0, via Wikimedia Commons

Medifast director Parsa Kiai buys $1.1 million of shares

Open market purchase reported on Form 4, filed Nov 20, 2026.

Octans ResearchPublished

Snapshot

Parsa Kiai, a director of Medifast (MED), bought 94,036 shares in open market purchases between Nov 18, 2026 and Nov 19, 2026, about $1.1 million at an average price of $12.06 a share, according to a Form 4 filed with the SEC on Nov 20, 2026.

Coverage
Independent Research
Prepared by
Octans Research
Tickers
MED
As of

Market Data

Latest prices for the companies covered in this article
Company1D %Price
($MED)▼ −1.92%11.75

as of 16:00 ET · Realtime derived data

What We Know

The filing lists 4 open market purchase lines: • Nov 18, 2026: 8,630 shares at $12.16. • Nov 18, 2026: 256 shares at $12.16. • Nov 19, 2026: 82,700 shares at $12.05. • Nov 19, 2026: 2,450 shares at $12.05.

After the last purchase, the filing reports 23,795 shares held indirectly in that account.

Octans View

An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought.

Bear Case · Room for Disagreement

Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.

Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.

Chart

$MED adjusted close, last 6 months $MED adjusted close, last 6 months: series falling from 13.1 to 11.8 (−10.2%) from 2026-05-26 to 2026-11-20. Scale 9 to 14. 91011121314 2026-05-262026-11-20 $MED ADJUSTED CLOSE, LAST 6 MONTHS −10.2% 11.75
Source: Tiingo · As of 2026-11-20Indicative, not investment advice.

Sources

  1. [1]SEC EDGAR — Form 4 filed by Parsa Kiai for Medifast, Nov 20, 2026

These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.

$1.1M

Parsa Kiai, a director of Medifast (MED), bought 94,036 shares in open market purchases between… · Snapshot

Related coverage

More on $MED

4 reports